Conditions: Migraines
Keywords: pain neuropathic pain headaches
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 63
Healthy volunteers: yes

Brief summary:
To evaluate the safety and tolerability of LY2951742 given as single or multiple subcutaneous injection in healthy male subjects

Detailed description:

Arms:
arm 1: Administered single subcutaneous injection arm 2: Administered single subcutaneous injection arm 3: Administered single subcutaneous injection arm 4: Administered single subcutaneous injection arm 5: Administered single subcutaneous injection arm 6: Administered single subcutaneous injection arm 7: Administered single subcutaneous injection arm 8: Administered subcutaneously every 2 weeks for 6 weeks (4 doses) arm 9: Administered subcutaneously every 2 weeks for 6 weeks (4 doses)

Interventions: intervention 1: LY2951742 intervention 2: Placebo
Intervention descriptions: intervention 1: Administered subcutaneously intervention 2: Administered subcutaneously

Protocol document: